Related Experiment Video
Updated: Jun 16, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Atorvastatin-induced prolonged cholestasis with bile duct damage
Manuela Merli1, Maria Consiglia Bragazzi, Federica Giubilo
1Division of Gastroenterology, Department of Clinical Medicine, University of Rome 'Sapienza', Rome, Italy.
Atorvastatin, a cholesterol-lowering drug, can cause prolonged cholestasis (bile flow obstruction) and bile duct damage. This rare drug-induced liver injury resolved after discontinuing the medication.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Gastroenterology
Background:
- Drug-induced liver injury (DILI) is a significant clinical concern.
- Statins, including atorvastatin, are widely prescribed for hyperlipidaemia.
- Cholestasis is a less common manifestation of DILI.
Observation:
- A 72-year-old male developed acute, prolonged cholestasis after 40 days of atorvastatin use for mixed dyslipidaemia.
- Symptoms included jaundice, asthenia, nausea, acholic stools, and hyperchromic urine.
- Biochemical tests revealed markedly elevated bilirubin and alkaline phosphatase levels, with moderate transaminase increases.
Findings:
- Liver histology demonstrated cholestasis with cholangiolitis and interlobular bile duct damage.
- Atorvastatin was identified as the probable cause using validated clinical scales (Maria and Victorino, Naranjo).
- Biochemical parameters normalized within 5-8 months post-atorvastatin withdrawal.
Implications:
- This case highlights a rare but severe form of DILI potentially caused by atorvastatin, characterized by prolonged cholestasis and bile duct injury.
- Physicians should consider atorvastatin as a potential etiology in patients presenting with unexplained cholestasis.
- Further research into the mechanisms of statin-induced cholestasis and bile duct damage is warranted.
Related Concept Videos
Cholecystitis
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...